Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo (Q39700720)

14 September 2017

title

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo (English)

1 reference

14 September 2017

0 references

1 reference

Helena Gleissman

1 reference

14 September 2017

Lova Segerström

1 reference

14 September 2017

Mats Hamberg

1 reference

14 September 2017

Frida Ponthan

1 reference

14 September 2017

Magnus Lindskog

1 reference

14 September 2017

John Inge Johnsen

1 reference

14 September 2017

Per Kogner

1 reference

14 September 2017

language of work or name

English

0 references

publication date

24 May 2010

1 reference

International Journal of Cancer

14 September 2017

published in

1 reference

14 September 2017

volume

128

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

1703-1711

1 reference

Neuroblastoma: biological insights into a clinical enigma

14 September 2017

cites work

1 reference

Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study

21 January 2018

1 reference

21 January 2018

1 reference

Multi-targeted therapy of cancer by omega-3 fatty acids

21 January 2018

1 reference

An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II.

21 January 2018

1 reference

Docosahexaenoic acid: membrane properties of a unique fatty acid

21 January 2018

1 reference

Fatty acids and neurodevelopment

21 January 2018

1 reference

Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells.

21 January 2018

1 reference

The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue

21 January 2018

1 reference

The opposing effects of n-3 and n-6 fatty acids

21 January 2018

1 reference

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation

21 January 2018

1 reference

Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets

21 January 2018

1 reference

Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo

21 January 2018

1 reference

Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.

21 January 2018

1 reference

Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.

21 January 2018

1 reference

Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress

21 January 2018

1 reference

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

21 January 2018

1 reference

The pediatric preclinical testing program: description of models and early testing results.

21 January 2018

1 reference

Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers

21 January 2018

1 reference

Gender differences in the n-3 fatty acid content of tissues

21 January 2018

1 reference

ROS stress in cancer cells and therapeutic implications

21 January 2018

1 reference

Cancer chemopreventive effects of polyunsaturated fatty acids

21 January 2018

1 reference

Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats

21 January 2018

1 reference

Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid

21 January 2018

1 reference

Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA

21 January 2018

1 reference

Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model

21 January 2018

1 reference

Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung

21 January 2018

1 reference

Effects of omega-3 fatty acid supplementation on tumor-bearing rats

21 January 2018

1 reference

Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy

21 January 2018

1 reference

Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-kappaB?

21 January 2018

1 reference

Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: impact on adhesion and apoptosis

21 January 2018

1 reference

Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil

21 January 2018

1 reference

Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of colo 201 human colon cancer cells

21 January 2018

1 reference

Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line

21 January 2018

1 reference

Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers.

21 January 2018

1 reference

Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids

21 January 2018

1 reference

Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha

21 January 2018

1 reference

Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids

21 January 2018

1 reference

Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain

21 January 2018

1 reference

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

21 January 2018

1 reference

Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression.

21 January 2018

1 reference

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial.

21 January 2018

1 reference

Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids

21 January 2018

1 reference

Childhood Cancer Among Alaska Natives

21 January 2018

1 reference

Gestational age and birth weight in relation to n-3 fatty acids among Inuit (Canada).

21 January 2018

1 reference

The importance of the ratio of omega-6/omega-3 essential fatty acids

21 January 2018

1 reference

Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk

21 January 2018

1 reference

Long-term fatty fish consumption and renal cell carcinoma incidence in women

21 January 2018

1 reference

Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study

21 January 2018

1 reference

Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.

21 January 2018

1 reference

Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25473

1 reference

14 September 2017

1 reference